Document Detail

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
MedLine Citation:
PMID:  20818439     Owner:  NLM     Status:  In-Process    
CD133 (prominin-1) is a transmembrane glycoprotein expressed on the surface of normal and cancer stem cells (tumor-initiating cells), progenitor cells, rod photoreceptor cells and a variety of epithelial cells. Although CD133 is widely used as a marker of various somatic and putative cancer stem cells, its contribution to the fundamental properties of cancer cells, such as tumorigenesis and differentiation, remains to be elucidated. In the present report, we found that CD133 was expressed in several neuroblastoma (NB) cell lines/tumor samples. Intriguingly, CD133 repressed NB cell differentiation, for example neurite extension and the expression of differentiation marker proteins, and was decreased by several differentiation stimuli, but accelerated cell proliferation, anchorage-independent colony formation and in vivo tumor formation of NB cells. NB cell line and primary tumor-sphere experiments indicated that the molecular mechanism of CD133-related differentiation suppression in NB was in part dependent on neurotrophic receptor RET tyrosine kinase regulation. RET transcription was suppressed by CD133 in NB cells and glial cell line-derived neurotrophic factor treatment failed to induce RET in CD133-expressing cells; RET overexpression rescued CD133-related inhibition of neurite elongation. Of note, CD133-related NB cell differentiation and RET repression were mainly dependent on p38MAPK and PI3K/Akt pathways. Furthermore, CD133 has a function in growth and RET expression in NB cell line- and primary tumor cell-derived tumor spheres. To the best of our knowledge, this is the first report of the function of CD133 in cancer cells and our findings may be applied to improve differentiation induction therapy for NB patients.
H Takenobu; O Shimozato; T Nakamura; H Ochiai; Y Yamaguchi; M Ohira; A Nakagawara; T Kamijo
Related Documents :
12106289 - Lateral mobility of the cell adhesion molecule l1 within the surface membrane of morpho...
1910809 - Mechanical properties of hl60 cells: role of stimulation and differentiation in retenti...
7877199 - An experimental study on membrane malignant phenotype of tumour cells and their reversion.
21304179 - P300- and myc-mediated regulation of glioblastoma multiforme cell differentiation.
21399919 - Toward a new role for plasma membrane sodium-dependent glutamate transporters of astroc...
19569129 - Icat as a potential enhancer of monocytic differentiation: implications from the compar...
16952509 - Altered expression pattern of heat shock transcription factor, y chromosome (hsfy) may ...
8856339 - Production of rotenone-inactivating substance(s) by rotenone-resistant insect cell line.
9125179 - Hemoglobin is utilized by candida albicans in the hyphal form but not yeast form.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-06
Journal Detail:
Title:  Oncogene     Volume:  30     ISSN:  1476-5594     ISO Abbreviation:  Oncogene     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  97-105     Citation Subset:  IM    
Division of Biochemistry and Molecular Carcinogenesis,Chiba Cancer Center Research Institute, Chiba, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor.
Next Document:  Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative al...